University of Rochester gets $4.5M From FDA to Study Clinical Pain Trials

The FDA will grant the University of Rochester Medical Center a $4.5 million grant over five years to study different approaches to improve methods used to evaluate and approve treatments for acute and chronic pain, according to a University news release.

Advertisement

Clinical trials of pain medication often produce less-than-ideal results because the control group, or patients receiving a placebo, often improve more than expected. A team of researchers will explore how the design of chronic and acute pain trials can be improved.

Related Articles on Pain Management:

Physicians Struggle to Treat Pain During Opioid Abuse Epidemic
Study: Naltrexone Use Prevents Relapse of Opioid Dependency
Nano-formulated NSAIDs Provide Relief at Lower Doses

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.